HealthEquity Statistics
Total Valuation
HealthEquity has a market cap or net worth of $7.80 billion. The enterprise value is $8.52 billion.
| Market Cap | 7.80B |
| Enterprise Value | 8.52B |
Important Dates
The last earnings date was Thursday, August 27, 2026, before market open.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthEquity has 82.72 million shares outstanding. The number of shares has decreased by -3.29% in one year.
| Current Share Class | 82.72M |
| Shares Outstanding | 82.72M |
| Shares Change (YoY) | -3.29% |
| Shares Change (QoQ) | -1.17% |
| Owned by Insiders (%) | 1.99% |
| Owned by Institutions (%) | 110.33% |
| Float | 81.04M |
Valuation Ratios
The trailing PE ratio is 34.06 and the forward PE ratio is 18.60. HealthEquity's PEG ratio is 1.14.
| PE Ratio | 34.06 |
| Forward PE | 18.60 |
| PS Ratio | 5.63 |
| Forward PS | 5.21 |
| PB Ratio | 3.86 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.71 |
| P/OCF Ratio | 15.64 |
| PEG Ratio | 1.14 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.31, with an EV/FCF ratio of 17.18.
| EV / Earnings | 35.43 |
| EV / Sales | 6.15 |
| EV / EBITDA | 16.31 |
| EV / EBIT | 23.54 |
| EV / FCF | 17.18 |
Financial Position
The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.49.
| Current Ratio | 2.99 |
| Quick Ratio | 2.46 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 1.88 |
| Debt / FCF | 1.99 |
| Interest Coverage | 6.78 |
Financial Efficiency
Return on equity (ROE) is 11.43% and return on invested capital (ROIC) is 9.97%.
| Return on Equity (ROE) | 11.43% |
| Return on Assets (ROA) | 6.65% |
| Return on Invested Capital (ROIC) | 9.97% |
| Return on Capital Employed (ROCE) | 11.42% |
| Weighted Average Cost of Capital (WACC) | 5.34% |
| Revenue Per Employee | $484,052 |
| Profits Per Employee | $84,042 |
| Employee Count | 2,814 |
| Asset Turnover | 0.41 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HealthEquity has paid $72.22 million in taxes.
| Income Tax | 72.22M |
| Effective Tax Rate | 23.39% |
Stock Price Statistics
The stock price has increased by +0.29% in the last 52 weeks. The beta is 0.23, so HealthEquity's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | +0.29% |
| 50-Day Moving Average | 99.48 |
| 200-Day Moving Average | 89.25 |
| Relative Strength Index (RSI) | 36.68 |
| Average Volume (20 Days) | 872,168 |
Short Selling Information
The latest short interest is 4.12 million, so 4.98% of the outstanding shares have been sold short.
| Short Interest | 4.12M |
| Short Previous Month | 4.17M |
| Short % of Shares Out | 4.98% |
| Short % of Float | 5.08% |
| Short Ratio (days to cover) | 5.83 |
Income Statement
In the last 12 months, HealthEquity had revenue of $1.36 billion and earned $236.49 million in profits. Earnings per share was $2.76.
| Revenue | 1.36B |
| Gross Profit | 970.48M |
| Operating Income | 355.98M |
| Pretax Income | 308.71M |
| Net Income | 236.49M |
| EBITDA | 513.61M |
| EBIT | 355.98M |
| Earnings Per Share (EPS) | $2.76 |
Balance Sheet
The company has $256.00 million in cash and $971.02 million in debt, with a net cash position of -$715.01 million or -$8.64 per share.
| Cash & Cash Equivalents | 256.00M |
| Total Debt | 971.02M |
| Net Cash | -715.01M |
| Net Cash Per Share | -$8.64 |
| Equity (Book Value) | 1.99B |
| Book Value Per Share | 24.00 |
| Working Capital | 306.43M |
Cash Flow
In the last 12 months, operating cash flow was $490.18 million and capital expenditures -$2.45 million, giving a free cash flow of $487.73 million.
| Operating Cash Flow | 490.18M |
| Capital Expenditures | -2.45M |
| Depreciation & Amortization | 157.63M |
| Net Borrowing | -76.88M |
| Free Cash Flow | 487.73M |
| FCF Per Share | $5.90 |
Margins
Gross margin is 71.25%, with operating and profit margins of 26.13% and 17.36%.
| Gross Margin | 71.25% |
| Operating Margin | 26.13% |
| Pretax Margin | 22.66% |
| Profit Margin | 17.36% |
| EBITDA Margin | 37.71% |
| EBIT Margin | 26.13% |
| FCF Margin | 35.81% |
Dividends & Yields
HealthEquity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.29% |
| Shareholder Yield | 3.29% |
| Earnings Yield | 3.09% |
| FCF Yield | 6.36% |
Analyst Forecast
The average price target for HealthEquity is $119.00, which is 26.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $119.00 |
| Price Target Difference | 26.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 6.70% |
| EPS Growth Forecast (3Y) | 12.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HealthEquity has an Altman Z-Score of 4.51 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.51 |
| Piotroski F-Score | 7 |